JPRN-jRCT1091220303
Recruiting
未知
A combined treatment for Alzheimer's dementia with hydrogen gas inhalation and reduced dose lithium. A randomized controlled clinical study. - H2LiTxDementia
Hirohisa Ono0 sites50 target enrollmentJuly 18, 2017
ConditionsAlzheimer's dementia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Alzheimer's dementia
- Sponsor
- Hirohisa Ono
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Alzheimer's dementia patient with confirmed worsening of clinical symptoms, MMSE score and ADAS score.
Exclusion Criteria
- •Dementia patient affected by other type of dementia rather than Alzheimer type, severe functional abnormality in the kidney, liver, pancreas and uncontrolled diabetes, lipidemia and hypertension.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
H8A-MC-LZAZPreclinical ADJPRN-jRCT2080223287Eli Lilly Japan K.K.1,150
Active, not recruiting
Phase 1
Dopaminergic therapy for Alzheimer's disease patientsAlzheimer's diseaseMedDRA version: 20.0Level: PTClassification code 10012271Term: Dementia Alzheimer's typeSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-002965-43-ITI.R.C.C.S. FONDAZIONE S.LUCIA130
Completed
Phase 2
A randomised trial for the treatment of AL amyloidosis with the high dose Green Tea Extract.ligh chain amyloidosisJPRN-UMIN000019732Japanese Red Cross Medical Center, Division of Hematology60
Active, not recruiting
Phase 1
Can a common blood pressure drug, losartan, help in Alzheimer's disease?Alzheimer's DiseaseTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2012-003641-15-GBorth Bristol NHS Trust228
Completed
Not Applicable
ithium for mild-to-moderate Alzheimer's disease: A randomized double-blind, placebo-controlled studyJPRN-UMIN000020128Department of Psychiatry, Fujita Health University School of Medicine100